fda compounding semaglutide crackdown news today 2025 The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the FDA is cracking down on

PMID 34815532

1 Specifically, two non-cleavable linkers, three acid-cleavable linkers, eight enzyme-cleavable linkers, and three contain GSH-cleavable linkers appeared in the fourteen approved ADCs (the linkers in Mylotarg and Besponsa are both acid-cleavable and GSH-cleavable, Table 1)

GLP-1 receptor agonists currently have a strong social media presence, often accompanied by unrealistic promises of weight loss

benefits are described in general, educational terms

This decline has prompted many to seek supplementation as a means of replenishing this vital antioxidant

Chicory Root Inulin Chicory root inulin is a prebiotic fiber